Correction to "Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease"

ACS Med Chem Lett. 2019 Aug 6;10(9):1357. doi: 10.1021/acsmedchemlett.9b00316. eCollection 2019 Sep 12.

Abstract

[This corrects the article DOI: 10.1021/acsmedchemlett.8b00507.].

Publication types

  • Published Erratum